{"id":"https://openalex.org/W3212420828","doi":"https://doi.org/10.1016/j.molmet.2021.101392","title":"Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic \u03b2-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries","display_name":"Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic \u03b2-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries","publication_year":2021,"publication_date":"2021-11-12","ids":{"openalex":"https://openalex.org/W3212420828","doi":"https://doi.org/10.1016/j.molmet.2021.101392","mag":"3212420828","pmid":"https://pubmed.ncbi.nlm.nih.gov/34781035","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8717237"},"language":"en","primary_location":{"id":"doi:10.1016/j.molmet.2021.101392","doi":"https://doi.org/10.1016/j.molmet.2021.101392","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molmet.2021.101392","pdf_url":null,"source":{"id":"https://openalex.org/S2764545133","display_name":"Molecular Metabolism","issn_l":"2212-8778","issn":["2212-8778"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.molmet.2021.101392","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055576755","display_name":"Brandon B. Boland","orcid":"https://orcid.org/0000-0003-1280-9547","observed_orcids":["https://orcid.org/0000-0003-1280-9547"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["DK","GB","US"],"is_corresponding":false,"raw_author_name":"Brandon B. Boland","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Gubra ApS, Horsholm, Denmark; PRECISIONscientia, Yardley, PA, USA","Gubra ApS, Horsholm, Denmark","PRECISIONscientia, Yardley, PA, USA","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Gubra ApS, Horsholm, Denmark; PRECISIONscientia, Yardley, PA, USA","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Gubra ApS, Horsholm, Denmark","institution_ids":["https://openalex.org/I4210113742"]},{"raw_affiliation_string":"PRECISIONscientia, Yardley, PA, USA","institution_ids":[]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004116492","display_name":"Rhianna Che Laker","orcid":"https://orcid.org/0000-0002-0507-7838","observed_orcids":["https://orcid.org/0000-0002-0507-7838"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Rhianna C. Laker","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035568313","display_name":"S. O'Brien","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Siobhan O'Brien","raw_affiliation_strings":["Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085206349","display_name":"Sadichha Sitaula","orcid":"https://orcid.org/0000-0003-4432-4173","observed_orcids":["https://orcid.org/0000-0003-4432-4173"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Sadichha Sitaula","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064516203","display_name":"Isabelle Sermadiras","orcid":"https://orcid.org/0000-0002-9443-9131","observed_orcids":["https://orcid.org/0000-0002-9443-9131"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Isabelle Sermadiras","raw_affiliation_strings":["Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104010613","display_name":"Jens Christian Nielsen","orcid":"https://orcid.org/0000-0002-6522-9987","observed_orcids":["https://orcid.org/0000-0002-6522-9987"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Jens Christian Nielsen","raw_affiliation_strings":["Gubra ApS, Horsholm, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra ApS, Horsholm, Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005450058","display_name":"Pernille Barkholt","orcid":"https://orcid.org/0000-0002-3603-2915","observed_orcids":["https://orcid.org/0000-0002-3603-2915"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Pernille Barkholt","raw_affiliation_strings":["Gubra ApS, Horsholm, Denmark"],"raw_orcid":"https://orcid.org/0000-0002-3603-2915","affiliations":[{"raw_affiliation_string":"Gubra ApS, Horsholm, Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051508866","display_name":"Urmas Roostalu","orcid":"https://orcid.org/0000-0002-7849-2055","observed_orcids":["https://orcid.org/0000-0002-7849-2055"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Urmas Roostalu","raw_affiliation_strings":["Gubra ApS, Horsholm, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra ApS, Horsholm, Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067103368","display_name":"Jacob Hecksher\u2010S\u00f8rensen","orcid":"https://orcid.org/0000-0002-5516-6177","observed_orcids":["https://orcid.org/0000-0002-5516-6177"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Jacob Hecksher-S\u00f8rensen","raw_affiliation_strings":["Gubra ApS, Horsholm, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra ApS, Horsholm, Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042601338","display_name":"Sara Rubek Sejthen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Sara Rubek Sejthen","raw_affiliation_strings":["Gubra ApS, Horsholm, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra ApS, Horsholm, Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029538911","display_name":"Ditte Dencker Thorbek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Ditte Dencker Thorbek","raw_affiliation_strings":["Gubra ApS, Horsholm, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra ApS, Horsholm, Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019731169","display_name":"Arthur T. Suckow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Arthur Suckow","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; DTX Pharma, San Diego, CA, USA","DTX Pharma, San Diego, CA, USA","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; DTX Pharma, San Diego, CA, USA","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"DTX Pharma, San Diego, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042999916","display_name":"Nicole Burmeister","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["DE","GB","US"],"is_corresponding":false,"raw_author_name":"Nicole Burmeister","raw_affiliation_strings":["Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Roche, Penzberg, Germany","Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","Roche, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Roche, Penzberg, Germany","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Roche, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046889578","display_name":"Stephanie N. Oldham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Stephanie Oldham","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021197756","display_name":"Sarah Will","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Sarah Will","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104100819","display_name":"VICTOR G. HOWARD","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Victor G. Howard","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013376281","display_name":"Benji M. Gill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Benji M. Gill","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Philip Newton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Philip Newton","raw_affiliation_strings":["Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036973706","display_name":"Jacqueline Naylor","orcid":"https://orcid.org/0000-0003-3939-9859","observed_orcids":["https://orcid.org/0000-0003-3939-9859"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Jacqueline Naylor","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033499723","display_name":"David C. Hornigold","orcid":"https://orcid.org/0000-0002-3354-2768","observed_orcids":["https://orcid.org/0000-0002-3354-2768"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"David C. Hornigold","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065017054","display_name":"Jotham R. Austin","orcid":"https://orcid.org/0000-0002-1070-9262","observed_orcids":["https://orcid.org/0000-0002-1070-9262"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jotham Austin","raw_affiliation_strings":["University of Chicago Advanced Electron Microscopy Core Facility, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Advanced Electron Microscopy Core Facility, Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075998503","display_name":"Louise Lantier","orcid":"https://orcid.org/0000-0002-6620-4976","observed_orcids":["https://orcid.org/0000-0002-6620-4976"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louise Lantier","raw_affiliation_strings":["Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA"],"raw_orcid":"https://orcid.org/0000-0002-6620-4976","affiliations":[{"raw_affiliation_string":"Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025336530","display_name":"Owen P. McGuinness","orcid":"https://orcid.org/0000-0002-1778-3203","observed_orcids":["https://orcid.org/0000-0002-1778-3203"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Owen P. McGuinness","raw_affiliation_strings":["Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031089096","display_name":"James L. Trevaskis","orcid":"https://orcid.org/0000-0002-5356-6118","observed_orcids":["https://orcid.org/0000-0002-5356-6118"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210106787","display_name":"Gilead Sciences (United Kingdom)","ror":"https://ror.org/01e11zd27","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James L. Trevaskis","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I105036370","https://openalex.org/I4210106787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084966112","display_name":"Joseph S. Grimsby","orcid":"https://orcid.org/0000-0002-0388-1427","observed_orcids":["https://orcid.org/0000-0002-0388-1427"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joseph S. Grimsby","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0002-0388-1427","affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101645946","display_name":"Christopher J. Rhodes","orcid":"https://orcid.org/0000-0002-7450-1110","observed_orcids":["https://orcid.org/0000-0002-7450-1110"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Christopher J. Rhodes","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. Electronic address: christopher.rhodes@astrazeneca.com"],"raw_orcid":"https://orcid.org/0000-0002-7450-1110","affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. Electronic address: christopher.rhodes@astrazeneca.com","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5101645946"],"corresponding_institution_ids":["https://openalex.org/I105036370"],"apc_list":{"value":3100,"currency":"USD","value_usd":3100},"apc_paid":{"value":3100,"currency":"USD","value_usd":3100},"fwci":2.7947,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.91451981,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"55","issue":null,"first_page":"101392","last_page":"101392"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7089999914169312,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7089999914169312,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.2506999969482422,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.02160000056028366,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pyy3-36","display_name":"PYY3-36","score":0.9570000171661377},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9800000190734863},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.5410000085830688},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":1.0},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.9829999804496765},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.9269999861717224},{"id":"https://openalex.org/keywords/gut-brain-axis","display_name":"gut-brain axis","score":0.953000009059906},{"id":"https://openalex.org/keywords/hepatic-glycogenesis","display_name":"hepatic glycogenesis","score":0.8019999861717224},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6309999823570251},{"id":"https://openalex.org/keywords/db-db-mice","display_name":"db/db mice","score":0.8339999914169312},{"id":"https://openalex.org/keywords/glucose-homeostasis","display_name":"glucose homeostasis","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8018420338630676},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7997336387634277},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.7140958309173584},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5410247445106506},{"id":"https://openalex.org/C3018667095","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Glucose homeostasis","level":4,"score":0.5245832800865173},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5157918930053711},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5094802975654602},{"id":"https://openalex.org/C2780796126","wikidata":"https://www.wikidata.org/wiki/Q290293","display_name":"Peptide YY","level":5,"score":0.49097302556037903},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.46167728304862976},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4600925147533417},{"id":"https://openalex.org/C2776129832","wikidata":"https://www.wikidata.org/wiki/Q22677256","display_name":"Gastric inhibitory polypeptide","level":4,"score":0.4553722143173218},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4357498288154602},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41834530234336853},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.352831095457077},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.35020869970321655},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3265826404094696},{"id":"https://openalex.org/C93984277","wikidata":"https://www.wikidata.org/wiki/Q24782073","display_name":"Neuropeptide Y receptor","level":4,"score":0.1831604540348053},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.17022964358329773}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002149","descriptor_name":"Energy Intake","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004032","descriptor_name":"Diet","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004435","descriptor_name":"Eating","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004734","descriptor_name":"Energy Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007031","descriptor_name":"Hypothalamus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008820","descriptor_name":"Mice, Obese","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D015390","descriptor_name":"Gastric Bypass","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019894","descriptor_name":"Peptide YY","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019894","descriptor_name":"Peptide YY","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D050417","descriptor_name":"Insulin-Secreting Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.molmet.2021.101392","doi":"https://doi.org/10.1016/j.molmet.2021.101392","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molmet.2021.101392","pdf_url":null,"source":{"id":"https://openalex.org/S2764545133","display_name":"Molecular Metabolism","issn_l":"2212-8778","issn":["2212-8778"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8717237","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8717237","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Metab","raw_type":"Text"},{"id":"pmid:34781035","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34781035","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b325ef86371a42baa07ae1549ba9e3b0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b325ef86371a42baa07ae1549ba9e3b0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Metabolism, Vol 55, Iss , Pp 101392- (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.molmet.2021.101392","doi":"https://doi.org/10.1016/j.molmet.2021.101392","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molmet.2021.101392","pdf_url":null,"source":{"id":"https://openalex.org/S2764545133","display_name":"Molecular Metabolism","issn_l":"2212-8778","issn":["2212-8778"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4099681973","display_name":"Vanderbilt Mouse Metabolic Phenotyping Center","funder_award_id":"U24DK059637","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G5436572433","display_name":null,"funder_award_id":"DK 059637","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":69,"referenced_works":["https://openalex.org/W342933987","https://openalex.org/W1916701653","https://openalex.org/W1937488454","https://openalex.org/W1965072462","https://openalex.org/W1975389666","https://openalex.org/W1975862819","https://openalex.org/W1978286730","https://openalex.org/W1983901940","https://openalex.org/W1987064421","https://openalex.org/W1990777401","https://openalex.org/W1991184946","https://openalex.org/W1992116679","https://openalex.org/W1997612728","https://openalex.org/W2020257755","https://openalex.org/W2020541351","https://openalex.org/W2027524238","https://openalex.org/W2052102985","https://openalex.org/W2056874715","https://openalex.org/W2068391384","https://openalex.org/W2068599805","https://openalex.org/W2079737026","https://openalex.org/W2086991865","https://openalex.org/W2088864173","https://openalex.org/W2089592096","https://openalex.org/W2091685843","https://openalex.org/W2096780893","https://openalex.org/W2102250923","https://openalex.org/W2102262987","https://openalex.org/W2106866775","https://openalex.org/W2128181185","https://openalex.org/W2133260492","https://openalex.org/W2145305950","https://openalex.org/W2145781698","https://openalex.org/W2154842844","https://openalex.org/W2155419918","https://openalex.org/W2167778120","https://openalex.org/W2167815036","https://openalex.org/W2168899316","https://openalex.org/W2169456326","https://openalex.org/W2179438025","https://openalex.org/W2198859596","https://openalex.org/W2303158138","https://openalex.org/W2319535267","https://openalex.org/W2338614470","https://openalex.org/W2550011910","https://openalex.org/W2610903113","https://openalex.org/W2755719114","https://openalex.org/W2772607655","https://openalex.org/W2786652970","https://openalex.org/W2795481136","https://openalex.org/W2797321538","https://openalex.org/W2897097523","https://openalex.org/W2900496024","https://openalex.org/W2900866106","https://openalex.org/W2905033532","https://openalex.org/W2911185744","https://openalex.org/W2912933215","https://openalex.org/W2914542939","https://openalex.org/W2914723344","https://openalex.org/W2922466138","https://openalex.org/W2942253286","https://openalex.org/W2944685885","https://openalex.org/W2950484331","https://openalex.org/W2950785405","https://openalex.org/W2956110875","https://openalex.org/W2984738555","https://openalex.org/W3027852565","https://openalex.org/W4239833383","https://openalex.org/W6821698098"],"related_works":["https://openalex.org/W2809447012","https://openalex.org/W1996857586","https://openalex.org/W2948946999","https://openalex.org/W4312030541","https://openalex.org/W3040856848","https://openalex.org/W4380319625","https://openalex.org/W2916440438","https://openalex.org/W4415817100","https://openalex.org/W2154842844","https://openalex.org/W2780627452"],"abstract_inverted_index":{"Obesity-linked":[0],"type":[1],"2":[2],"diabetes":[3],"(T2D)":[4],"is":[5,180],"a":[6,38,183,217],"worldwide":[7],"health":[8],"concern":[9],"and":[10,20,33,57,75,93,98,140,155,172,190,206,226],"many":[11],"novel":[12],"approaches":[13],"are":[14],"being":[15],"considered":[16],"for":[17,143,182,220],"its":[18],"treatment":[19],"subsequent":[21],"prevention":[22],"of":[23,27,50,73,87,110,122,130,134,138,164,201,203,244],"serious":[24],"comorbidities.":[25],"Co-administration":[26,133],"glucagon":[28],"like":[29],"peptide":[30,34,55],"1":[31],"(GLP-1)":[32],"YY3-36":[35],"(PYY3-36)":[36],"renders":[37],"synergistic":[39,84],"decrease":[40],"in":[41,44,96,148,160,169,186,242],"energy":[42],"intake":[43],"obese":[45,97,165,174],"men.":[46],"However,":[47],"mechanistic":[48],"details":[49],"the":[51,83,204,235,239],"synergy":[52],"between":[53,238],"these":[54],"agonists":[56],"their":[58,88],"effects":[59,109],"on":[60,90,114],"metabolic":[61,245],"homeostasis":[62],"remain":[63],"relatively":[64],"scarce.":[65],"In":[66],"this":[67],"study,":[68],"we":[69],"utilized":[70],"long-acting":[71,135],"analogues":[72],"GLP-1":[74],"PYY3-36":[76],"(via":[77],"Fc-peptide":[78],"conjugation)":[79],"to":[80,106,127],"better":[81],"characterize":[82],"pharmacological":[85],"benefits":[86],"co-administration":[89],"body":[91],"weight":[92,150],"glycaemic":[94],"regulation":[95],"diabetic":[99],"mouse":[100,162],"models.":[101],"Hyperinsulinemic-euglycemic":[102,167],"clamps":[103,168],"were":[104],"used":[105],"measure":[107],"weight-independent":[108,184],"Fc-PYY3-36":[111,141,209],"+":[112,210],"Fc-GLP-1":[113,139],"insulin":[115,188,224],"action.":[116],"Fluorescent":[117],"light":[118],"sheet":[119],"microscopy":[120],"analysis":[121],"whole":[123],"brain":[124,131],"was":[125],"performed":[126],"assess":[128],"activation":[129,200],"regions.":[132],"Fc-IgG/peptide":[136],"conjugates":[137],"(specific":[142],"PYY":[144],"receptor-2":[145],"(Y2R))":[146],"resulted":[147],"profound":[149],"loss,":[151],"restored":[152,227],"glucose":[153],"homeostasis,":[154],"recovered":[156],"endogenous":[157,228],"\u03b2-cell":[158,229],"function":[159],"two":[161],"models":[163],"T2D.":[166],"C57BLKS/J":[170],"db/db":[171],"diet-induced":[173],"Y2R-deficient":[175],"(Y2RKO)":[176],"mice":[177],"indicated":[178],"Y2R":[179],"required":[181],"improvement":[185],"peripheral":[187],"sensitivity":[189,225],"enhanced":[191],"hepatic":[192],"glycogenesis.":[193],"Brain":[194],"cFos":[195],"staining":[196],"demonstrated":[197],"distinct":[198],"temporal":[199],"regions":[202],"hypothalamus":[205],"hindbrain":[207],"following":[208],"Fc-GLP-1R":[211],"agonist":[212],"administration.":[213],"These":[214,231],"results":[215],"reveal":[216],"therapeutic":[218],"approach":[219],"obesity/T2D":[221],"that":[222],"improved":[223],"function.":[230],"data":[232],"also":[233],"highlight":[234],"potential":[236],"association":[237],"gut\u2013brain":[240],"axis":[241],"control":[243],"homeostasis.":[246]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-11-22T00:00:00"}